Literature DB >> 15453854

Ascorbic acid reversibly inhibits proliferation of retinal pigment epithelial cells.

A Heckelen1, M Hermel, B Kondring, N F Schrage.   

Abstract

PURPOSE: Proliferation control in adult retinal pigment epithelial (ARPE) cells is an essential factor in the clinical management of proliferative vitreoretinopathy (PVR). Factors which inhibit PVR and which are without toxic potential are therefore of interest in controlling proliferation. The aim of the present study was to gain insight into a possible function of high intraocular ascorbic acid levels as a physiological modulator of proliferation.
METHODS: Adult retinal pigment epithelial cells were incubated in vitro with increasing concentrations of ascorbic acid (0.5-4 mmol, pH 7.4). Cell proliferation was assayed by the bromide-deoxy-uridine (BrdU) assay. The culture medium (CM) containing ascorbic acid was replaced with normal CM and the recovery of proliferation was measured after 24 hours. In order to be able to distinguish between proliferation inhibition, apoptosis, necrosis and recovery of proliferation, we performed TUNEL assays and fluorescence analysis cell-counter (FAC) analysis.
RESULTS: Ascorbic acid significantly inhibits ARPE cell proliferation if it is present in concentrations above 2 mmol. Proliferation resumed in all ARPE cell cultures after pre-incubation with ascorbic acid, indicating that direct toxicity of ascorbic acid is a negligible factor. The time-point and extent of recovery in proliferation was dependent on the initial ascorbic acid concentration. Fluorescence-labelled cell counts on apoptosis markers (FAC) data showed some induction of apoptosis and necrosis after incubation with 4 mmol ascorbic acid.
CONCLUSIONS: Ascorbic acid has a dose-dependent influence on the proliferation of vital ARPE cells. This possibly reflects the role of ascorbic acid at a physiological level within the vitreous cavity in preventing proliferative vitreoretinopathy (PVR). These findings may stimulate the development of new strategies in the clinical treatment of PVR.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15453854     DOI: 10.1111/j.1600-0420.2004.00317.x

Source DB:  PubMed          Journal:  Acta Ophthalmol Scand        ISSN: 1395-3907


  6 in total

1.  [Chemical and thermal eye burns. Conservatíve and surgical options of a stage-dependent therapy].

Authors:  H G Struck; N F Schrage
Journal:  Ophthalmologe       Date:  2011-10       Impact factor: 1.059

2.  Lack of antioxidative properties of vitamin C and pyruvate in cultured retinal pigment epithelial cells.

Authors:  Oliver Zeitz; Lars Schlichting; Gisbert Richard; Olaf Strauss
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-02       Impact factor: 3.117

3.  Ascorbic acid promotes cardiomyogenesis through SMAD1 signaling in differentiating mouse embryonic stem cells.

Authors:  Maria Grazia Perino; Satoshi Yamanaka; Daniel R Riordon; Yelena Tarasova; Kenneth R Boheler
Journal:  PLoS One       Date:  2017-12-12       Impact factor: 3.240

4.  Vitamin C improves the therapeutic potential of human amniotic epithelial cells in premature ovarian insufficiency disease.

Authors:  Shunyu Hou; Chenyue Ding; Han Shen; Chunfeng Qian; Qinyan Zou; Jiafeng Lu; Boxian Huang; Jichun Tan; Hong Li
Journal:  Stem Cell Res Ther       Date:  2020-04-22       Impact factor: 6.832

5.  Isolation and characterization of a spontaneously immortalized bovine retinal pigmented epithelial cell line.

Authors:  Thomas E Liggett; T Daniel Griffiths; Elizabeth R Gaillard
Journal:  BMC Cell Biol       Date:  2009-05-04       Impact factor: 4.241

6.  Antiproliferative effect of ascorbic acid is associated with the inhibition of genes necessary to cell cycle progression.

Authors:  Sophie Belin; Ferdinand Kaya; Ghislaine Duisit; Sarah Giacometti; Joseph Ciccolini; Michel Fontés
Journal:  PLoS One       Date:  2009-02-06       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.